PCVX
Vaxcyte
$59.97
−$0.46 (−0.76%)Oct 26, 2026
Key metrics
The numbers that frame PCVX today
- Market cap
- $8.92B
- ROIC
- -37.8%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $39.87
- 52wk High
- $90.75
Growth
Revenue and earnings trend for PCVX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PCVX
Is Vaxcyte a good buy?
Hold. Vaxcyte has strong momentum, but poor quality makes the setup mixed. Growth looks strong, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Vaxcyte is selling at a very high price.
What is the market capitalization of PCVX?
Vaxcyte's market capitalization is $8.92B.
What is the 52-week high for PCVX stock?
The 52-week high for Vaxcyte is $90.75. The current close of $59.97 is 33.9% below that high.
What is the 52-week low for PCVX stock?
The 52-week low for Vaxcyte is $39.87. The current close of $59.97 is 50.4% above that low.
Does PCVX stock pay dividends?
Vaxcyte does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PCVX?
Vaxcyte's Debt / Equity ratio is 0.04.